EUVIMEDEUVIMED entdecken
Crossref

Synthesis, anticancer activity and mechanism of action of Fe(III) complexes

Xiaoqian Zhao, Ying Qian, Shanshan Hu, Yingbiao Tian iD

Drug Development Research · 2024

DOI: 10.1002/ddr.22264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Xiaoqian Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kweichow Moutai Hospital, Renhuai, Guizhou, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ferric Compounds, Apoptosis, Reactive Oxygen Species. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To inhibit the growth and metastasis of triple‐negative breast cancer (TNBC), two Fe(III) thiosemicarbazone complexes ( Fe1 and Fe2 ) were designed and synthesized. The structures of the Fe(III) complexes were characterized by single crystal X‐ray diffraction. The antiproliferative activity of Fe1 and Fe2 against four cancer lines (MDA‐MB‐231, T98G, HepG2, 143B) and human renal proximal tubular epithelial cell line (HK‐2) was evaluated by MTT assay. Among all cells, Fe2 showed significant cytotoxicity to TNBC cells (MDA‐MB‐231), with an IC 50 value of 12.38 μM. Furthermore, Fe2 showed less toxicity to HK‐2 cells. The two Fe(III) complexes can produce excess of reactive oxygen species, decrease of mitochondrial membrane potential, and induce DNA damage, then lead to apoptosis of MDA‐MB‐231 cells. In addition, Fe1 and Fe2 can also inhibit migration and invasion of MDA‐MB‐231 cells. This study provides guidance for the development of metal complexes that inhibit the growth and metastasis of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsFerric CompoundsApoptosisReactive Oxygen SpeciesMembrane Potential, MitochondrialHumansCell Line, TumorCell ProliferationCell MovementCoordination ComplexesThiosemicarbazonesDNA DamageTriple Negative Breast NeoplasmsDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

Fe(III) complexTNBCanticancerantimetastasisapoptosis

Substanzen

Antineoplastic AgentsFerric CompoundsReactive Oxygen SpeciesCoordination ComplexesThiosemicarbazones

Autor:innen und Institutionen

  • Kweichow Moutai Hospital, Renhuai, Guizhou, China.
  • Affiliated Hospital of Zunyi Medical University, Guizhou, China.

ORCID-Profile: Yingbiao Tian

Zitieren

APA

Zhao, X., Qian, Y., Hu, S., & Tian, Y. (2024). Synthesis, anticancer activity and mechanism of action of Fe(III) complexes. Drug Development Research. https://doi.org/10.1002/ddr.22264

Vancouver

Zhao X, Qian Y, Hu S, Tian Y. Synthesis, anticancer activity and mechanism of action of Fe(III) complexes. Drug Development Research. 2024. doi:10.1002/ddr.22264

BibTeX
@article{Zhao2024,
  author = {Zhao, Xiaoqian and Qian, Ying and Hu, Shanshan and Tian, Yingbiao},
  title = {Synthesis, anticancer activity and mechanism of action of Fe(III) complexes},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22264}
}
Kostenlos starten →